The Safety and Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers

Clinical trial NCT03669562 · UNKNOWN

Trial details

NCT number: NCT03669562
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lower Extremity Arterial Occlusive Diseases

Start date: 2018-08-07
Primary completion: 2018-10-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.